Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a05:640c:3013:b0:1ee:4bd3:5fc9 with SMTP id z19csp264482eiw;
        Sat, 20 Jan 2024 13:58:22 -0800 (PST)
X-Google-Smtp-Source: AGHT+IFOh8LiozAKSRn2SSHkHyC1gAzJk5YXfVjCrNh/xeZiNXKI8IN9mojiuCUoQrliTINo3TMu
X-Received: by 2002:a05:620a:24c1:b0:783:3499:8011 with SMTP id m1-20020a05620a24c100b0078334998011mr3478112qkn.88.1705787902036;
        Sat, 20 Jan 2024 13:58:22 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705787902; cv=none;
        d=google.com; s=arc-20160816;
        b=mTdGO6tyEijgfjVDzyGJyRSZvKNr0f0nG88e0FRmn3giyQn1RhcVSIO+uh7/O/+B3x
         ZuXwvvOU4xfIPyq0Izqm9PTfZQUSme+FIxa9asm3TmoyWFlmLQnNkjELqeeyRkXzT8YO
         KNF6LCUcyHci98NkOIublx9Ss1tNmt/ajCUreBv2VJprsPVguf6r6PG6VhccpgoNKvUN
         z/P60o3doMkf3PabUfaCRKTF7EJaMTHCh9Bv0mtNp/uZhISShJCkGbVRinjM6bj6g+65
         qsaP7hkF+YzwXErkM136YzWGMy6amB2YDmU2y1pe5YIsgr1a9gl+7Vem4AUrOdT/mEf9
         MaKQ==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=jv8codeHQ3Dj/32G6C2EsiwvcwcvkniTf42MIz0ueZY=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=gqT08RYnPQ2cCKb1KW9dbWOPKrMQVK2cCJlUgzZtz9CIKKaffo8xnGtgBb1lmb5U/c
         pCAbNCNu3jsFhRKDbstmjadFZAp6EedmDsOaSC26VE4HALzpMlajXyL0svAAKQXv9d3L
         mqWl/UBTuaECVpbtSnc1Q+ZKtN6R1wRMMAAiGA9hun6jh67hahCnYkxh+gyxWPUtHxdM
         3S2zj8S8EH4/G2VnE9tSfum43jf2vk9tq72SLfHXmFSSb5etc5CRvyJQzpsDkklr4H5q
         kD6+/g1HYbqrPeEgNAjiEPxkSLND8w53PboFx4y/lNHTDEEpmXleHzByf3u9sCdL0OjI
         e0dA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=SCNSP2tN;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=qsBph1rz;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id x3-20020a05620a0ec300b0078329ba5054si2185958qkm.193.2024.01.20.13.58.21
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Sat, 20 Jan 2024 13:58:22 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=SCNSP2tN;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=qsBph1rz;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=jv8codeHQ3Dj/32G6C2EsiwvcwcvkniTf42MIz0ueZY=;
	b=SCNSP2tNT5QTntZXCAO9d3Wtcthg2fqHb6nNPE7606obBJ2WqSMleDv4HyTukP+BKwbl
	Ab2sqOWXmtZVmHyf8bFuzY/y6QdACDk0TkFn2suHZMWaK7aMKgIcGjsL6Me2bRHZlyoBXq
	y7hlTf/u0VeZhhTP+P6Qr59m9hV5P6m8mZSYKOVVbrC9SlcIb0hVywf7vSaPobo+/ELrgU
	C0VK5KX0qWRc4lAiasGyWlVpbeJTpzonr0tjS9t2dlDwx/FCDr6cGiYbbLD+f66FUYXykK
	xLuGVeIYnSQKrydWE9J+64i4fcMEzKiNyqPCsubo0qD8XiajI2Izz7gSPFZJGBnA==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=jv8codeHQ3Dj/32G6C2EsiwvcwcvkniTf42MIz0ueZY=;
	b=qsBph1rzIXhQFyTfQ3nVKX1Y2McFPRSfDVZIVzIzgvcfW9X8ngiIc8rxfc8Vw2IbvNQ4
	1ZPnrjYny0s9MjWKEqNgFuPvshezv+Bfbt3BuJm3o+B+kAMOpSv0A3hkTNRr5G1ffkUoQ8
	LjoiK2woEEvWjUNlGOXCTGo1F5nc+ZS1o=
Received: by filterdrecv-7d848c6fdf-bp8p2 with SMTP id filterdrecv-7d848c6fdf-bp8p2-1-65AC41FC-7
        2024-01-20 21:58:20.152051628 +0000 UTC m=+8219792.195965574
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-4 (SG) with HTTP
	id P4kkDRoKQjSHgHCN9UakEw
	Sat, 20 Jan 2024 21:58:20.132 +0000 (UTC)
Content-Type: multipart/alternative; boundary=14b9818168bac48943b28384dd1512061905640e11cae292e6f8c2193c65
Date: Sat, 20 Jan 2024 21:58:21 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <P4kkDRoKQjSHgHCN9UakEw@geopod-ismtpd-4>
Subject: PRO/EDR> Measles - Argentina: (SA) unimmunized, no travel
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iB21BGAEAwZp8S1ndw4QulSNcSpZJc+dAwuEi1S?=
 =?us-ascii?Q?qqgF7dS9M2lw=2F5V+bli34KU1QkPek8T3SXuJMzt?=
 =?us-ascii?Q?wH2Amr=2FhHNob7rSPqH4yBPHTZ=2Fb4KM2ZoaMcNhS?=
 =?us-ascii?Q?YWbgWNLH23DkftrLITUYCiyqjRbaopAoD40XHaB?=
 =?us-ascii?Q?5broC3FNKvlSWqSmfoqm+bnssHaw0aCcN9jEKz?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4YTE7Z=2Fero?=
 =?us-ascii?Q?U2yujr2Nvw9iY7sBT51qIZvM0f7gGBM0W8aHobK?=
 =?us-ascii?Q?KfHAuJ+7X7MQKCgn3C+Kam=2Fh61KoqNyWMZzv3w5?=
 =?us-ascii?Q?+qcAWt0zCLjWejAiN=2F0R=2FwSe+nLtlHnmIg7Yb5g?=
 =?us-ascii?Q?hWUBMCv0uS3NaJciZvcFOvvqu0dz6rRaE9c3Be7?=
 =?us-ascii?Q?KLNvDsOx8WT+uem7YrlkUZ9LcGlGaIJKaMuKE2y?=
 =?us-ascii?Q?qds4iYTRAJ+1emnQpHXtJpPj04gBJ7rkRBXOJ+z?=
 =?us-ascii?Q?ctKBUCQAq1VT1yguGLAo+jpjST9YzZdLnR5hUqp?=
 =?us-ascii?Q?YBclh=2Fh8D0qRdqGD2NCHsorxjRTPo7ek7xPVw=2Fj?=
 =?us-ascii?Q?mNYx35OYo7vk97LnMMFVS+RXbdCuYTLmrVas9ZN?=
 =?us-ascii?Q?doqFPaQH7bdH1BqgiIr1TTPR5E1eTx+HGPN06qS?=
 =?us-ascii?Q?ZHDSWcl5t0WqfpLjzKVwqSG6bZaAfhi53aQ859x?=
 =?us-ascii?Q?sW=2F5STuEKtzySTvkR0A+Mb=2FCU6+mindpHZkL8V6?=
 =?us-ascii?Q?kCv0MbobXVll+ytGX1ZvRFtcugSHWpsgNgHiIMf?=
 =?us-ascii?Q?LAaivXNfdwb2E90cUUh0=2F3umGEteSVsxqr10U00?=
 =?us-ascii?Q?1eD=2FwuRmOm7Iqw0nQ+m0saEwqRdiqIex47HMCxZ?=
 =?us-ascii?Q?zJVSxmlaj0I4DO25ASI0wwYsdQ=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2E4LKAdsRXX?=
 =?us-ascii?Q?Lbr-NGQaCbYdq6Edjb0JW6FYMv=5FxOpCwQRoMDAw?=
 =?us-ascii?Q?dTAwMKfIlulvslZiVv0YEqQ9ND9swmUY9U6sk1Y?=
 =?us-ascii?Q?EryR1yZ2KrcREr9syPRYaALXbI1URN4z3MZS7n3?=
 =?us-ascii?Q?8Hd1R9bDsNxHgZTtPjjAoNOaowc50udkKDu5Ro1?=
 =?us-ascii?Q?eMYkDLys1W3ldNUNA=3D=3D=2Ev=5F76xpIJ8f5xyQ33rfK?=
 =?us-ascii?Q?fdHsr7KzPA8CA2IbZVj-iL65oMDAwdTAwMCIAT5?=
 =?us-ascii?Q?wd22tAp6UYoAb6CRmhYdqYGqiuuGC3NrnOn8s0y?=
 =?us-ascii?Q?2ah75nFka7=5FeNrqv1LfAJfCktkeIG2fWjA8s4xK?=
 =?us-ascii?Q?d2avRAiVd7L5XM0y4S7oK5mcWuPqvRA-=5FSUP63I?=
 =?us-ascii?Q?jTXtm=5FfXGGys2POKWjq1s0k2PY4RALx7lOEGSAC?=
 =?us-ascii?Q?V=5FnZhv2dMh5bI7STqw7e7PKONY0QcOfWDKodCzg?=
 =?us-ascii?Q?8CDSYPLQQ1qz3npOmfB6Kk5npFvqHJYIEDmEWRp?=
 =?us-ascii?Q?AhCivPvq=5Fi5yi=5FjTFRO03fwg8n2dG8GHjHmJAi9?=
 =?us-ascii?Q?Ye4kTMjZBHm3gUJzNGuIVHjDOV0BtF-SrLRomZy?=
 =?us-ascii?Q?tkVURiNovCsVeX3sxdYGFEWKtRZPvJRYNmn6jo7?=
 =?us-ascii?Q?yvmGcMhdra1lvoyrLpKFe73oqDelGRDIHGRDhHg?=
 =?us-ascii?Q?PSwXYmDxm0vWUfVlwq07o3bBU=5FrEcyp-F5fZcrz?=
 =?us-ascii?Q?8iQ5unQPHZ-UpGe0b2RFjB1L0zHUM=5FCm-lnmo99?=
 =?us-ascii?Q?ww8-C2w1J1r-WhmFAAJXpfcKoSiGNPFQGirxokX?=
 =?us-ascii?Q?XHmFd4ZHnOSC8lerzR7QVbCRzKRAMlLIkdXdO0v?=
 =?us-ascii?Q?uFsSVwgLJu9RKdViR122IttqMukn-U-WjwaWwqq?=
 =?us-ascii?Q?iHiPgRCaQoQG7caM2IX8=5FZR99zM-c9KcuPW-EJH?=
 =?us-ascii?Q?VzvDXfeqQSc=5FCQypiLYkCjCVunkWv7u8qsPWSsZ?=
 =?us-ascii?Q?qarFMziAmZfNjQH3XS0or2LNA1VhCL-WDq7-gbL?=
 =?us-ascii?Q?npg1dN=5FWHDEpJlcsuPzHt8rcdCfJRoBe55QrTsk?=
 =?us-ascii?Q?Fx-4cpbekRUztYpQcd7QTbkQT5NDfwhHaL1JTSh?=
 =?us-ascii?Q?f0ZJUxz-EI=5FXwGvN8XVeTrkA7Jc1YmejER4b3fg?=
 =?us-ascii?Q?R9zHRfVNtvq1KY-T8kJ7VfMPm03Y3IZMO5yx=5FWD?=
 =?us-ascii?Q?tTQw9VbyapdKe-AQAp=5F=5F12GOo1iRQPDQLK9JtAo?=
 =?us-ascii?Q?VRptGv95sUtbeqRUoyAx98eCL9Dq540fAoo9Tvp?=
 =?us-ascii?Q?frW=5FVRDUBc=5FyEEJURfhiC4pRtWOhMZf4qDAt7p9?=
 =?us-ascii?Q?N6tg-AinLru7iAdJDtiAaMM=3E?=

--14b9818168bac48943b28384dd1512061905640e11cae292e6f8c2193c65
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=iso-8859-1
Mime-Version: 1.0

MEASLES - ARGENTINA: (SALTA) UNIMMUNIZED, NO TRAVEL
***************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Fri 19 Jan 2024
Source: T=E9lam [in Spanish, machine trans., edited]
<https://www.telam.com.ar/notas/202401/653050-el-ministerio-de-salud-de-sal=
ta-confirmo-un-caso-de-sarampion-en-un-nino.html>


A 19-month-old child who was not vaccinated, was treated in the
private sector, and has no travel history was confirmed this Friday
[19 Jan 2024] by the Anlis-Malbr=E1n National Reference Laboratory for
infection by serology and detection of the measles virus, the Ministry
of Health, Salta, reported.

Last Tuesday [16 Jan 2024], a private health worker from Salta
notified the National Health Surveillance System of a case of febrile
exanthematous illness, suspected of measles, for which the
epidemiological investigation and control actions began. This is a
child who was not vaccinated against measles, had no travel history,
and, from the initial investigation, there was no contact with
suspected cases before the onset of symptoms.

"The child presented fever, rash, cough, and conjunctivitis on 2 Jan
[2024]; 3 days later he consulted and was hospitalized for pneumonia
in a private clinic, presenting isolation of pneumococcus in a
respiratory sample. On 9 Jan [2024], a serum sample was taken, and on
16 Jan [2024], positive IgM for measles was reported in a private
laboratory," said spokespersons for the Salta health ministry.

This serum sample, along with others for viral detection, were
referred to the Anlis-Malbr=E1n National Reference Laboratory, which
confirmed the infection by serology and detection of measles virus by
RT-PCR in urine and nasopharyngeal aspirate. The provincial Ministry
of Health indicated that studies to genotype the virus are being
developed.

The local and provincial rapid response teams (ERRA) are currently
carrying out the epidemiological investigation and the corresponding
outbreak control actions. For this reason, the Salta health
authorities emphasized that, to sustain the achievements of measles
elimination and avoid the reintroduction of the virus to the country,
it is necessary to achieve and sustain high vaccination coverage with
2 doses of measles vaccine (with or without the mumps and rubella
vaccines) and a sensitive surveillance system capable of timely
detecting suspicious cases and thus preventing their spread.

According to the national calendar, the vaccination schedule
establishes that, from 12 months to 4 years, one dose of triple viral
vaccine (measles, mumps, rubella) must be accredited. Those over 5
years of age, adolescents, and adults born after 1965 must have at
least 2 doses of vaccine with a measles component applied after one
year of age (double or triple viral) or have positive IgG serology for
measles.

--
Communicated by:
ProMED
via
ProMED-ESP

[Generally, the rubeola virus is acquired by an unvaccinated traveler
from an area where measles circulates commonly and then presents in a
developed country where measles is uncommon due to an aggressive
vaccination program. It is often the case, in my experience, that the
index case is seen in a primary care setting like an emergency room
and is not promptly diagnosed and isolated, so secondary cases in
individuals not vaccinated by choice or too young to be vaccinated
occur. What is notable here is that there was no travel. It is
important to trace where the infant was and who the infant was exposed
to.

Additionally, originally the live attenuated measles vaccine, which
requires a cold chain, was even more heat unstable than now, and a
large outbreak of measles occurred in the 1980s in some individuals
who were likely immunized with vaccine that was improperly stored. In
addition to a formulation that was somewhat more heat stable, the
measles vaccine is now given as a 2-shot sequence instead of one.
Although some of the cases presented somewhat atypically, I personally
saw cases of classical measles with the high fever and descending rash
that were overtly misdiagnosed by others.

A relatively recent review of this potentially fatal preventable
disease follows:

Moss WJ. Measles. Lancet. 2017; 390(10111): 2490-2502;
<https://doi.org/10.1016/S0140-6736(17)31463-0>.
---------------------------------------------------------------------------=
---------------------------
Abstract
-------
"Measles is a highly contagious disease that results from infection
with measles virus and is still responsible for more than 100 000
deaths every year, down from more than 2 million deaths annually
before the introduction and widespread use of measles vaccine. Measles
virus is transmitted by the respiratory route, and illness begins with
fever, cough, coryza, and conjunctivitis followed by a characteristic
rash. Complications of measles affect most organ systems, with
pneumonia accounting for most measles-associated morbidity and
mortality. The management of patients with measles includes provision
of vitamin A. Measles is best prevented through vaccination, and the
major reductions in measles incidence and mortality have renewed
interest in regional elimination and global eradication. However,
urgent efforts are needed to increase stagnating global coverage with
2 doses of measles vaccine through advocacy, education, and the
strengthening of routine immunisation systems. Use of combined
measles-rubella vaccines provides an opportunity to eliminate rubella
and congenital rubella syndrome. Ongoing research efforts, including
the development of point-of-care diagnostics and microneedle patches,
will facilitate progress towards measles elimination and
eradication."

Salta is a province of Argentina, located in the northwest of the
country. Neighboring provinces are, clockwise from the east, Formosa,
Chaco, Santiago del Estero, Tucum=E1n, and Catamarca. It lies south of
and partially surrounds Jujuy province. To the north it borders
Bolivia and Paraguay, and to the west lies Chile. - Mod.LL

ProMED map:
Salta, Argentina:
<https://promedmail.org/promed-post?place=3D8714361,44291>]

[See Also:
Measles - Malaysia (01): (SA) low vaccination coverage
http://promedmail.org/post/20240120.8714352
Measles - UK (01): national incident declaration
http://promedmail.org/post/20240120.8714349
Measles - Canada (01): (SK) international travel
http://promedmail.org/post/20240120.8714348
Measles - USA (03): (GA) international travel, RFI
http://promedmail.org/post/20240120.8714347
Measles - USA (02): multiple states
http://promedmail.org/post/20240118.8714292
Measles - Portugal: (LI) imported
http://promedmail.org/post/20240116.8714250
Measles - Israel: (north) nosocomial
http://promedmail.org/post/20240113.8714196
Measles update (01): USA (PA) multiple potential exposure sites
http://promedmail.org/post/20240107.8714111
2023
----
Measles update (16): Australia, USA (UT), Malaysia, Africa (Libya)
http://promedmail.org/post/20230330.8709238
Measles update (15): South Africa, Philippines, Sudan (West Darfur)
RFI http://promedmail.org/post/20230324.8709124
Measles update (14): India (MP, JH) Armenia, WHO
http://promedmail.org/post/20230316.8708981
Measles update (13): Indonesia (CP) Samoa, Mauritania (NT)
http://promedmail.org/post/20230312.8708895
Measles update (11): Ghana, South Africa, India, USA
http://promedmail.org/post/20230227.8708629
Measles update (05): Indonesia, India, South Africa, research
http://promedmail.org/post/20230130.8708055
Measles update (04): India, Afghanistan, USA
http://promedmail.org/post/20230123.8707937
Measles update (03): Afghanistan, Serbia, India, DRC
http://promedmail.org/post/20230117.8707833
Measles update (02): India (UP), South Africa (GT)
http://promedmail.org/post/20230109.8707703
Measles update (01): Russia (SA), India (MH), USA (OH)
http://promedmail.org/post/20230101.8707573]
.................................................jt/ll/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DaUVh7zZQLcf-YJNBM9lBtKLSu2v_OSZQZgYiTvOGX-hoMDAwdTAwMGxZqa5=
e5IxQK_HjA-sJjkflMc-zI2mvpoOILTVqo1dTEe1BtLaoCJlELyVqQ3WgzFitAkpe_OuLfMAw7c=
tWv6v0iDaaLAiXvkAxZxHM_8PzSK3Kev4FZJAm_CT-ut8rEA7bIKMF6r6KtM3TawNteGAwQVc_L=
S7Vd_FwwkWVUBhDc5M0SXs0O27vb8WxH5GJ_0ai_bnj993SzYyAt9WKuYX-iGF-E58t1GI-vDQZ=
K8Fd5mvTKk2tyWu-pY3McqJmwKFEdKZah6y0qv_PxYBqi4W1HQTBOIxEpiGIXXKWJvcKN2HU2Lq=
wb3lyi3dR4a6zJg5xUbsw_O7zC8W6CA_aSsGeEtUlUZeh6x3eAE822WGRRDpep4takO-ARSAwOo=
pO_EPTfgKWvWOmpEMD31eeBZ2bBeZgc9PqzJ7g-hJOG8_hs_-wHNj8u2ufjZZpxyvbW-V7VUW4D=
KhZNM0HJEf7oGOFAO_6i9C9MCT2rHV_PbiUZXIHmn5HGN8SI2vYIuZJ8XVwiXpUQh8w5NhL4xxp=
7gHfE2MegYzMRecCa_2-prvFGWB4wJCr1lExU3VtNjpsdN6h3mj_LHmuwlYKs4wlmD9Jv-RB8QC=
hxdeQc6jxVFscqDgdol6tToQ0bCj5ee34_-9FB9ikxwbiP49F2cIy_0GpQDAQxs-OkNqQBoN_2I=
Nma45PAgM2ntPAvjwOC0en6AfmZWy4L7IddP-MSpNYBwTqitFUB_m3-2H-6i3XNW9tpavcWtYuQ=
zEH5wn06B_fi9AkbKJj1oU1iblcCgfWbFAxVsRq74CCdFVT6LBAYeVQ0UpMdDilKy2ewPeicL56=
KLBWBBRGIeR2jiKoyhRjVcFgxw2wGxMlFx9g-iIEcKmb2ty_cFHRUxJ6R7cMlOC3zj50cw2WV2f=
2qaqC1fnp6duQA1MzSAla6o1QbgMWL8w0woXzIDI_wFWFRTn6CBOjvoRmWzwJtlYEVRZV87gdqa=
uj7uwl6cUuDgTPTtNBMfcUszjNfVLjMcIGcFbWARdyqEYmb5gwYRiVfjV7R-TMVEdlWJEjQX-1Y=
bEVCMwYSNewAh-M936dhVDF6mgIkQOcdsTdvR3piBhY8VcuqkXq-36ncSwvWFXIMucZAxfuzws8=
FAFGPXE_uttelXOjWsLZek_8XCaVkNLH4fZd7zThN2k=3D )
############################################################
############################################################

--14b9818168bac48943b28384dd1512061905640e11cae292e6f8c2193c65
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=iso-8859-1
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MEASLES - ARGENTINA: (SALTA) UNIMMUNIZED, NO TRAVEL<br>**************=
*************************************<br>A ProMED-mail post<br><a href=3D"h=
ttps://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-=
YZGnfgDOxU1G3gjwnPSi2Tfv3HA/435/zxLkq134QX2fWo4C7SUJUw/h0/1wBwML4hOUSa4iiUe=
xqmd3sK9jRUdU9q3crlZPnaPXo">http://www.promedmail.org</a><br>ProMED-mail is=
 a program of the<br>International Society for Infectious Diseases<br><a hr=
ef=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Up=
m3qyMCbcYSQvc/435/zxLkq134QX2fWo4C7SUJUw/h1/NbhxMKp3yZ-YHA89Q9WzCC8SYcioD_z=
YPMZJKjxX02k">http://www.isid.org</a><br><br>Date: Fri 19 Jan 2024=0D<br>So=
urce: T=E9lam [in Spanish, machine trans., edited]=0D<br><a href=3D"https:/=
/u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMam_PZzkzvKt9jq8BnF7RlvN0=
1dNMI4UoVYlVgeNr_e-FHUbh4aBAlWXP19r-twpnfm3o4OaSmgvKaiemL6uIobqhAKlf1pksLxN=
qh0roTyBN-rqTF7gi5MLpbIHuXHUOJLlG97h48MsTPJs0C-YVSAN1gM3bXeEMyu5JfY7ebTmPf/=
435/zxLkq134QX2fWo4C7SUJUw/h2/avz1u_jrUJMDmoHQlA4TaTMDNPMhgOlUjFJyGw5g5v8">=
https://www.telam.com.ar/notas/202401/653050-el-ministerio-de-salud-de-salt=
a-confirmo-un-caso-de-sarampion-en-un-nino.html</a>=0D<br>=0D<br>=0D<br>A 1=
9-month-old child who was not vaccinated, was treated in the<br>private sec=
tor, and has no travel history was confirmed this Friday<br>[19 Jan 2024] b=
y the Anlis-Malbr=E1n National Reference Laboratory for<br>infection by ser=
ology and detection of the measles virus, the Ministry<br>of Health, Salta,=
 reported.=0D<br>=0D<br>Last Tuesday [16 Jan 2024], a private health worker=
 from Salta<br>notified the National Health Surveillance System of a case o=
f febrile<br>exanthematous illness, suspected of measles, for which the<br>=
epidemiological investigation and control actions began. This is a<br>child=
 who was not vaccinated against measles, had no travel history,<br>and, fro=
m the initial investigation, there was no contact with<br>suspected cases b=
efore the onset of symptoms.=0D<br>=0D<br>"The child presented fever, rash,=
 cough, and conjunctivitis on 2 Jan<br>[2024]; 3 days later he consulted an=
d was hospitalized for pneumonia<br>in a private clinic, presenting isolati=
on of pneumococcus in a<br>respiratory sample. On 9 Jan [2024], a serum sam=
ple was taken, and on<br>16 Jan [2024], positive IgM for measles was report=
ed in a private<br>laboratory," said spokespersons for the Salta health min=
istry.=0D<br>=0D<br>This serum sample, along with others for viral detectio=
n, were<br>referred to the Anlis-Malbr=E1n National Reference Laboratory, w=
hich<br>confirmed the infection by serology and detection of measles virus =
by<br>RT-PCR in urine and nasopharyngeal aspirate. The provincial Ministry<=
br>of Health indicated that studies to genotype the virus are being<br>deve=
loped.=0D<br>=0D<br>The local and provincial rapid response teams (ERRA) ar=
e currently<br>carrying out the epidemiological investigation and the corre=
sponding<br>outbreak control actions. For this reason, the Salta health<br>=
authorities emphasized that, to sustain the achievements of measles<br>elim=
ination and avoid the reintroduction of the virus to the country,<br>it is =
necessary to achieve and sustain high vaccination coverage with<br>2 doses =
of measles vaccine (with or without the mumps and rubella<br>vaccines) and =
a sensitive surveillance system capable of timely<br>detecting suspicious c=
ases and thus preventing their spread.=0D<br>=0D<br>According to the nation=
al calendar, the vaccination schedule<br>establishes that, from 12 months t=
o 4 years, one dose of triple viral<br>vaccine (measles, mumps, rubella) mu=
st be accredited. Those over 5<br>years of age, adolescents, and adults bor=
n after 1965 must have at<br>least 2 doses of vaccine with a measles compon=
ent applied after one<br>year of age (double or triple viral) or have posit=
ive IgG serology for<br>measles.=0D<br>=0D<br>--=0D<br>Communicated by:=0D<=
br>ProMED=0D<br>via=0D<br>ProMED-ESP<br><br>[Generally, the rubeola virus i=
s acquired by an unvaccinated traveler<br>from an area where measles circul=
ates commonly and then presents in a<br>developed country where measles is =
uncommon due to an aggressive<br>vaccination program. It is often the case,=
 in my experience, that the<br>index case is seen in a primary care setting=
 like an emergency room<br>and is not promptly diagnosed and isolated, so s=
econdary cases in<br>individuals not vaccinated by choice or too young to b=
e vaccinated<br>occur. What is notable here is that there was no travel. It=
 is<br>important to trace where the infant was and who the infant was expos=
ed<br>to.=0D<br>=0D<br>Additionally, originally the live attenuated measles=
 vaccine, which<br>requires a cold chain, was even more heat unstable than =
now, and a<br>large outbreak of measles occurred in the 1980s in some indiv=
iduals<br>who were likely immunized with vaccine that was improperly stored=
. In<br>addition to a formulation that was somewhat more heat stable, the<b=
r>measles vaccine is now given as a 2-shot sequence instead of one.<br>Alth=
ough some of the cases presented somewhat atypically, I personally<br>saw c=
ases of classical measles with the high fever and descending rash<br>that w=
ere overtly misdiagnosed by others.=0D<br>=0D<br>A relatively recent review=
 of this potentially fatal preventable<br>disease follows:=0D<br>=0D<br>Mos=
s WJ. Measles. Lancet. 2017; 390(10111): 2490-2502;<br><a href=3D"https://u=
19268662.ct.sendgrid.net/ss/c/TUIVIg4PCmni5tP3Q8lzBb5MugwcowHsZrFMKbC9gdZXj=
JfO1ofBkVp65S9HwcsP0B9TU-cN1rQReYPuBfmk_w/435/zxLkq134QX2fWo4C7SUJUw/h3/Pld=
HiNmpFRw9MUHTqDQiW5Qd75Ok9MKobRWrE2vN9gs">https://doi.org/10.1016/S0140-673=
6(17)31463-0</a>.=0D<br>---------------------------------------------------=
---------------------------------------------------=0D<br>Abstract=0D<br>--=
-----=0D<br>"Measles is a highly contagious disease that results from infec=
tion<br>with measles virus and is still responsible for more than 100 000<b=
r>deaths every year, down from more than 2 million deaths annually<br>befor=
e the introduction and widespread use of measles vaccine. Measles<br>virus =
is transmitted by the respiratory route, and illness begins with<br>fever, =
cough, coryza, and conjunctivitis followed by a characteristic<br>rash. Com=
plications of measles affect most organ systems, with<br>pneumonia accounti=
ng for most measles-associated morbidity and<br>mortality. The management o=
f patients with measles includes provision<br>of vitamin A. Measles is best=
 prevented through vaccination, and the<br>major reductions in measles inci=
dence and mortality have renewed<br>interest in regional elimination and gl=
obal eradication. However,<br>urgent efforts are needed to increase stagnat=
ing global coverage with<br>2 doses of measles vaccine through advocacy, ed=
ucation, and the<br>strengthening of routine immunisation systems. Use of c=
ombined<br>measles-rubella vaccines provides an opportunity to eliminate ru=
bella<br>and congenital rubella syndrome. Ongoing research efforts, includi=
ng<br>the development of point-of-care diagnostics and microneedle patches,=
<br>will facilitate progress towards measles elimination and<br>eradication=
."=0D<br>=0D<br>Salta is a province of Argentina, located in the northwest =
of the<br>country. Neighboring provinces are, clockwise from the east, Form=
osa,<br>Chaco, Santiago del Estero, Tucum=E1n, and Catamarca. It lies south=
 of<br>and partially surrounds Jujuy province. To the north it borders<br>B=
olivia and Paraguay, and to the west lies Chile. - Mod.LL<br><br>ProMED map=
:<br>Salta, Argentina:<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c=
/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yThczCD4sOABK=
_nx1zLC_c-tg/435/zxLkq134QX2fWo4C7SUJUw/h4/9c7mxw4KkpUpZq1IygTl79CHNeqv5P3F=
i9S0ycnPBZ8">https://promedmail.org/promed-post?place=3D8714361,44291</a>]<=
br><br>[See Also:<br>Measles - Malaysia (01): (SA) low vaccination coverage=
<br>http://promedmail.org/post/20240120.8714352=0D<br>Measles - UK (01): na=
tional incident declaration<br>http://promedmail.org/post/20240120.8714349=0D=
<br>Measles - Canada (01): (SK) international travel<br>http://promedmail.o=
rg/post/20240120.8714348=0D<br>Measles - USA (03): (GA) international trave=
l, RFI<br>http://promedmail.org/post/20240120.8714347=0D<br>Measles - USA (=
02): multiple states<br>http://promedmail.org/post/20240118.8714292=0D<br>M=
easles - Portugal: (LI) imported<br>http://promedmail.org/post/20240116.871=
4250=0D<br>Measles - Israel: (north) nosocomial<br>http://promedmail.org/po=
st/20240113.8714196=0D<br>Measles update (01): USA (PA) multiple potential =
exposure sites<br>http://promedmail.org/post/20240107.8714111=0D<br>2023=0D=
<br>----=0D<br>Measles update (16): Australia, USA (UT), Malaysia, Africa (=
Libya)<br>http://promedmail.org/post/20230330.8709238=0D<br>Measles update =
(15): South Africa, Philippines, Sudan (West Darfur)<br>RFI http://promedma=
il.org/post/20230324.8709124=0D<br>Measles update (14): India (MP, JH) Arme=
nia, WHO<br>http://promedmail.org/post/20230316.8708981=0D<br>Measles updat=
e (13): Indonesia (CP) Samoa, Mauritania (NT)<br>http://promedmail.org/post=
/20230312.8708895=0D<br>Measles update (11): Ghana, South Africa, India, US=
A<br>http://promedmail.org/post/20230227.8708629=0D<br>Measles update (05):=
 Indonesia, India, South Africa, research<br>http://promedmail.org/post/202=
30130.8708055=0D<br>Measles update (04): India, Afghanistan, USA<br>http://=
promedmail.org/post/20230123.8707937=0D<br>Measles update (03): Afghanistan=
, Serbia, India, DRC<br>http://promedmail.org/post/20230117.8707833=0D<br>M=
easles update (02): India (UP), South Africa (GT)<br>http://promedmail.org/=
post/20230109.8707703=0D<br>Measles update (01): Russia (SA), India (MH), U=
SA (OH)<br>http://promedmail.org/post/20230101.8707573]<br>................=
.................................jt/ll/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DaUVh7zZQLcf-YJNBM9lBtKLSu2v_OSZQZgYiTvOGX-hoMDAwdT=
AwMGxZqa5e5IxQK_HjA-sJjkflMc-zI2mvpoOILTVqo1dTEe1BtLaoCJlELyVqQ3WgzFitAkpe_=
OuLfMAw7ctWv6v0iDaaLAiXvkAxZxHM_8PzSK3Kev4FZJAm_CT-ut8rEA7bIKMF6r6KtM3TawNt=
eGAwQVc_LS7Vd_FwwkWVUBhDc5M0SXs0O27vb8WxH5GJ_0ai_bnj993SzYyAt9WKuYX-iGF-E58=
t1GI-vDQZK8Fd5mvTKk2tyWu-pY3McqJmwKFEdKZah6y0qv_PxYBqi4W1HQTBOIxEpiGIXXKWJv=
cKN2HU2Lqwb3lyi3dR4a6zJg5xUbsw_O7zC8W6CA_aSsGeEtUlUZeh6x3eAE822WGRRDpep4tak=
O-ARSAwOopO_EPTfgKWvWOmpEMD31eeBZ2bBeZgc9PqzJ7g-hJOG8_hs_-wHNj8u2ufjZZpxyvb=
W-V7VUW4DKhZNM0HJEf7oGOFAO_6i9C9MCT2rHV_PbiUZXIHmn5HGN8SI2vYIuZJ8XVwiXpUQh8=
w5NhL4xxp7gHfE2MegYzMRecCa_2-prvFGWB4wJCr1lExU3VtNjpsdN6h3mj_LHmuwlYKs4wlmD=
9Jv-RB8QChxdeQc6jxVFscqDgdol6tToQ0bCj5ee34_-9FB9ikxwbiP49F2cIy_0GpQDAQxs-Ok=
NqQBoN_2INma45PAgM2ntPAvjwOC0en6AfmZWy4L7IddP-MSpNYBwTqitFUB_m3-2H-6i3XNW9t=
pavcWtYuQzEH5wn06B_fi9AkbKJj1oU1iblcCgfWbFAxVsRq74CCdFVT6LBAYeVQ0UpMdDilKy2=
ewPeicL56KLBWBBRGIeR2jiKoyhRjVcFgxw2wGxMlFx9g-iIEcKmb2ty_cFHRUxJ6R7cMlOC3zj=
50cw2WV2f2qaqC1fnp6duQA1MzSAla6o1QbgMWL8w0woXzIDI_wFWFRTn6CBOjvoRmWzwJtlYEV=
RZV87gdqauj7uwl6cUuDgTPTtNBMfcUszjNfVLjMcIGcFbWARdyqEYmb5gwYRiVfjV7R-TMVEdl=
WJEjQX-1YbEVCMwYSNewAh-M936dhVDF6mgIkQOcdsTdvR3piBhY8VcuqkXq-36ncSwvWFXIMuc=
ZAxfuzws8FAFGPXE_uttelXOjWsLZek_8XCaVkNLH4fZd7zThN2k=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/435/zxLkq134QX2fWo4C7SUJUw/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--14b9818168bac48943b28384dd1512061905640e11cae292e6f8c2193c65--
